Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.
| Licence number | Project title | Organisation | Category | Release | Issue date | Licence status |
|---|---|---|---|---|---|---|
Clinical trial of a genetically modified (GM) chimeric Orthopoxvirus (CF33-hNIS) as a cancer treatment |
Medpace Australia Pty Ltd |
Medical | Limited and controlled | Application under evaluation | ||
Clinical trial of a genetically modified alphavirus for treatment of cancer |
VRT Pharmaceuticals Pty Ltd |
Medical | Limited and controlled | |||
Clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough |
PPD Australia Pty Ltd |
Medical | Limited and controlled | Current | ||
Clinical trial with a genetically modified human adenovirus COVID-19 vaccine |
Avance Clinical Pty Ltd |
Medical | Limited and controlled | Current | ||
Clinical trial with genetically modified E.coli to reduce antibiotic resistance |
The Westmead Institute for Medical Research |
Medical | Limited and controlled | Current | ||
Commercial supply of a genetically modified COVID-19 vaccine |
Janssen-Cilag Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial of a genetically modified Herpes virus for the treatment of cystic fibrosis |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Commercial supply of a genetically modified COVID-19 vaccine |
AstraZeneca Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial with a genetically modified Vaccinia virus based treatment for solid cancerous tumours |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Clinical trial of genetically modified human adenovirus for bladder cancer treatment |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Commercial supply of a genetically modified cholera vaccine, Vaxchora® |
Biocelect Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial of genetically modified influenza vaccine (H3N2 M2SR) |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Limited and controlled release of microalgae genetically modified for increased production of fatty acids |
The University of Queensland |
Other | Limited and controlled | Current | ||
A genetically modified respiratory syncytial virus (RSV) vaccine for use in clinical trials |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Limited and controlled release of genetically modified insect-specific viruses as vaccines against Kunjin virus infection in farmed crocodiles |
The University of Queensland |
Medical | Limited and controlled | Current | ||
Commercial supply of Dengvaxia, an attenuated GM dengue vaccine |
Sanofi-Aventis Australia Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial of live attenuated genetically modified influenza vaccines |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Clinical trial of a genetically modified virus for treatment of liver, kidney and prostate cancer |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Commercial supply of attenuated GM influenza vaccines |
AstraZeneca Pty Ltd |
Medical | Commercial | Current | ||
Commercial supply of a tumour-selective genetically modified virus for cancer therapy |
Amgen Australia Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial of a genetically modified vaccine against Cholera |
PaxVax Australia Pty Ltd |
Medical | Limited and controlled | Surrendered | ||
Limited and Controlled Release Of Genetically Modified Live Viral Vaccines Against Prostate Cancer |
PPD Australia Pty Ltd |
Medical | Limited and controlled | Surrendered | ||
Commercial release of a genetically modified live viral vaccine to protect against Japanese encephalitis (IMOJEV™) |
Sanofi-Aventis Australia Pty Ltd |
Medical | Commercial | Current | ||
Limited and controlled release of a genetically modified vaccine for prevention of selected childhood respiratory diseases |
PPD Australia Pty Ltd |
Medical | Limited and controlled | Ceased | ||
Commercial release of GloFish™ expressing red, green or yellow fluorescent proteins |
Yorktown Technologies |
Other | Commercial | Withdrawn | ||
Commercial release of recombinant live oral cholera vaccine (Orochol® vaccine) |
CSL Ltd |
Medical | Commercial | Surrendered |